|
Sr. No
|
Title of the projects
|
Funding agency
|
Fund
|
Duration
|
|
1
|
Nanozyme incorporated Light-Responsive Hydrogel as Angiogenic Antibacterial Wound Dressing for Treating Diabetic Foot Ulcer
|
CSIR-ASPIRE
|
29.71 L
|
2024-2027
|
|
1
|
Antibacterial Nanozyme-Laden in situ Light-Responsive Hydrogel for Tissue Regeneration and Quorum-Sensing Inhibition to Revert Antimicrobial Resistance in Diabetic Foot Ulcers
|
ICMR
|
48.02 L
|
2023-2026
|
|
2
|
Revolutionizing Phototherapy with Hypoxia-Reversing Photothermal/ Photodynamic Nanoparticles-Laden In Situ Gel for Non-Invasive Tumor Ablation in Oral Cancer
|
ICMR
|
53.13 L
|
2023-2026
|
|
3
|
Brain-Targeted Antibacterial Nanomedicine to Revolutionize the Existing Therapy for Bacterial Meningitis
|
ICMR
|
55.08 L
|
2023-2026
|
|
4
|
3D-Bioprinted Contact Lens Embedding Host-Defense Peptide S100A12 as Precision Medicine for Bacterial Keratitis
|
DBT
|
39.10 L
|
2023- Feb 2025
|
|
5
|
Carbon dioxide-fueled Janus Motors for Targeted Delivery of Therapeutic Cargo in Helicobacter pylori Infection
|
MoE-STARS
|
46.85 L
|
2023-2026
|
|
6
|
Tailor-made, Tumor-Targeted Vitaprotein Nanoparticles of Lapatinib and Letrozole as NanoChemo-Cocktail for Hormone-Receptor-Amplified Advanced Metastatic Breast Cancers Treatment
|
ICMR
|
29.76 L
|
2023-2026
|
|
7
|
Near-Infrared Light Degradable Nanomicellar Chemo-Photodynamic Therapy using Aerobic Chlorin e6 Conjugate for Oropharyngeal Carcinomas
|
DST-SERB-Core Research Grant
|
30.72 L
|
2019-2022
|
|
8
|
Understanding the role of antimicrobial peptide S100A12 (Calgranulin C) in Host Defense during Pseudomonas Keratitis and Developing nano-tools for efficient Delivery of S100A12
|
DST-SERB (E.M.R./2016/001514)
(PI from BITS-Pilani)
|
55 L
|
2017-2020
|
|
9
|
Development of paclitaxel nano-formulation (CONSULTANCY)
|
Dr. Reddy's Laboratory, Hyderabad, India
|
8.27 L
|
2017-2019
|
|
10
|
Development of epigenomes-targeted liposomes for the cancer-specific delivery of chemotherapeutic drug
|
Sun Pharmaceutical Advanced Research Company, Vadodara, India
|
29 L
|
2016-2019
|
|
11
|
Sustained release injectable depot formulation
|
Daewoong Pharmaceuticals, Hyderabad, India
|
22 L
|
2015-2017
|
|
12
|
Tumor-targeted nanomedicines for photodynamic therapy
|
DST (Indo-Belarus)
|
9.58 L
|
2015-2017
|
|
13
|
D-α tocopherol conjugated copolymer-based micelles for improved delivery of chemotherapeutics with reversal of multiple drug resistance
|
DST-Fast Track
|
22.4 L
|
2014-2017
|
|
14
|
Cell-penetrating peptide octa-arginine anchored, multifunctional poly(amidoamine) dendrimer to promote the delivery of chemotherapeutics in cancer
|
DBT-BIO-CARe
|
37.04 L
|
2014-2017
|
An Institute of Eminence
